+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Enteral Nutrition Market - Global Forecast 2026-2032- Product Image
Enteral Nutrition Market - Global Forecast 2026-2032- Product Image
Sale

Enteral Nutrition Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4989698
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Enteral Nutrition Market is projected to reach USD 7.74 Billion in 2026. It is expected to continue growing at a CAGR of 10.17%, reaching USD 13.99 Billion by 2032.

Enteral nutrition is a critical segment of medical nutrition therapy, delivering nutrients through the gastrointestinal tract for patients who cannot meet requirements through oral intake alone. Demand is supported by the documented rise in chronic disease, cancer care, neurological disorders, premature birth complications, and age-related dysphagia, alongside the United Nations projection that people aged 65 and older will account for about 16% of the global population by 2050.

The market is increasingly shaped by evidence-based clinical nutrition guidelines from organizations such as ESPEN and ASPEN, which support early nutritional intervention to improve outcomes in appropriate patients. Commercial growth is strongest where hospitals, home healthcare providers, pharmacies, and long-term care facilities align on disease-specific enteral formulas, feeding tubes, pumps, and remote monitoring workflows.

Transformative Shifts in the Enteral Nutrition Landscape

The enteral nutrition landscape is shifting from hospital-centered feeding to integrated care across acute, post-acute, and home settings. This transition is driven by pressure to reduce hospital length of stay, improve recovery, reduce avoidable complications, and support patients with long-term nutritional needs. Home enteral nutrition is gaining relevance as health systems expand outpatient services and caregivers receive better training on tube feeding protocols, pump use, hygiene, and tolerance monitoring.

Product innovation is also changing competition. High-protein, peptide-based, diabetes-specific, renal, immune-modulating, pediatric, and fiber-enriched formulas are increasingly used to address complex metabolic needs across intensive care, oncology, neurology, gastrointestinal disease, and long-term care. At the same time, stricter medical device and food safety requirements are raising the bar for labeling, traceability, tube connectors, contamination prevention, and post-market surveillance.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to create cumulative value across enteral nutrition by improving screening, personalization, adherence, and supply planning. AI-enabled clinical decision support can help identify malnutrition risk from electronic health records, flag patients who may benefit from dietitian assessment, and support formula selection based on weight, diagnosis, laboratory trends, medication interactions, and gastrointestinal tolerance.

In operations, predictive analytics can improve pump fleet utilization, inventory planning, recall management, and last-mile delivery for home enteral nutrition. AI can also support remote monitoring by detecting patterns in feeding interruptions, intolerance symptoms, and adherence gaps. However, adoption depends on validated algorithms, clinician oversight, cybersecurity, HIPAA-compliant data handling in the United States, GDPR-aligned practices in Europe, and transparent governance to avoid bias in nutrition care pathways.

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Asia-Pacific is a high-growth enteral nutrition region due to large patient populations, rapid hospital expansion, rising diabetes prevalence, and advanced aging in markets such as Japan, China, South Korea, and Australia. India and Southeast Asia add long-term potential as critical care capacity, oncology services, neonatal care, and private healthcare networks expand. The region also reflects strong demand for affordable, locally adapted formulas and education-led adoption among clinicians and caregivers.

North America benefits from advanced clinical nutrition practice, established home healthcare infrastructure, specialized dietitian networks, and structured reimbursement pathways, particularly in the United States and Canada. Europe is shaped by aging populations, hospital quality standards, clinical nutrition protocols, and European Union medical device regulation, creating strong emphasis on safety, evidence, and procurement compliance. Latin America shows increasing demand through Brazil and Mexico, supported by expanding hospital services and chronic disease care, although access remains uneven across public and private systems. The Middle East is expanding specialty care capacity, particularly in the GCC, where tertiary hospitals, diabetes care, oncology, and long-term care services are priorities. Africa presents significant unmet need linked to malnutrition, critical care gaps, limited reimbursement, and supply constraints, making access, affordability, and resilient distribution central to adoption.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN markets are expanding as universal health coverage initiatives, private hospitals, medical tourism hubs, and nutrition programs increase access to tube feeding and specialized formulas. The GCC is driven by high diabetes and obesity burdens, investment in tertiary hospitals, and demand for advanced clinical nutrition in oncology, intensive care, rehabilitation, and long-term care.

The European Union emphasizes safety, labeling, procurement quality, traceability, and clinical evidence, making compliance a competitive differentiator. BRICS countries offer scale through large patient pools and healthcare modernization, although affordability, reimbursement, local manufacturing, and distribution remain critical. G7 markets set benchmarks for evidence-based practice, reimbursement, home care standards, and digital health adoption, while NATO countries increasingly prioritize resilient healthcare supply chains for essential medical products, including enteral feeding systems, pumps, connectors, and specialized nutrition formulas.

Key Country Insights Across Major Enteral Nutrition Markets

The United States leads through advanced hospital nutrition teams, home infusion providers, specialty pharmacies, and broad use of disease-specific enteral formulas, while Canada relies on provincial coverage models, strong clinical standards, and coordinated home care pathways. Mexico and Brazil show rising demand through public health systems and private providers, especially in critical care, oncology, diabetes care, and postoperative recovery.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are supported by aging populations, dietitian-led care pathways, hospital nutrition screening, and reimbursement structures, while Russia focuses on domestic healthcare capacity, localized supply, and access across large geographies. China and India represent major growth markets because of population scale, diabetes prevalence, hospital investment, expanding oncology care, and rising awareness of medical nutrition therapy. Japan, Australia, and South Korea show mature demand linked to aging, long-term care, advanced reimbursement systems, and established clinical protocols for tube feeding in hospitals and home settings.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated, disease-specific formulations that align with ESPEN, ASPEN, and local nutrition guidance. Manufacturers should strengthen evidence generation through real-world outcomes data, especially in intensive care, oncology, diabetes, renal disease, gastrointestinal disorders, pediatrics, and home enteral nutrition.

Commercial teams should invest in caregiver education, dietitian engagement, digital adherence tools, safe tube-feeding training, and logistics reliability. Regional strategies must reflect reimbursement differences, procurement rules, regulatory requirements, cultural preferences, and affordability constraints. Organizations that combine product quality, AI-enabled service models, safety compliance, clinical education, and resilient supply chains will be best positioned to support long-term adoption.

Research Methodology

This executive summary is grounded in secondary research from recognized public health, regulatory, and clinical nutrition sources, including WHO, United Nations demographic data, OECD health indicators, national health agencies, ESPEN and ASPEN guidance, and regional regulatory frameworks. Market interpretation incorporates demand drivers such as aging, chronic disease prevalence, hospital capacity, home healthcare growth, nutrition screening, medical device safety, and medical nutrition innovation.

The analysis uses triangulation across clinical guidelines, epidemiological trends, reimbursement structures, product adoption patterns, regulatory standards, and healthcare infrastructure indicators. Insights are structured to support market visibility for enteral nutrition market research, medical nutrition therapy, tube feeding, home enteral nutrition, disease-specific enteral formulas, clinical nutrition, and enteral feeding devices, without relying on market sizing, market share, or forecasting claims.

Conclusion

Enteral nutrition is moving from a supportive therapy to a strategic component of patient-centered care, chronic disease management, postoperative recovery, critical care, and home healthcare. Growth in adoption is underpinned by aging demographics, rising clinical complexity, improved nutrition screening, and demand for specialized formulas that support measurable outcomes.

The next phase of competition will depend on clinical evidence, regional access strategies, AI-enabled care coordination, regulatory compliance, and supply chain reliability. Organizations that deliver safe, compliant, data-supported, affordable, and patient-friendly enteral nutrition solutions are positioned to strengthen adoption across both mature and emerging healthcare systems.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Enteral Nutrition Market, by Product Type
7.1. Introduction
7.2. Blenderized Diet
7.3. Specialized Formulas
7.3.1. Disease Specific
7.3.1.1. Diabetic
7.3.1.2. Hepatic
7.3.1.3. Pulmonary
7.3.1.4. Renal
7.3.2. Fiber Enriched
7.3.3. Immune Modulating
7.3.4. Probiotic Supplemented
7.4. Standard Formulas
7.4.1. Modular
7.4.2. Oligomeric
7.4.3. Polymeric
8. Enteral Nutrition Market, by Form
8.1. Introduction
8.2. Liquid
8.3. Powder
9. Enteral Nutrition Market, by Route Of Administration
9.1. Introduction
9.2. Oral Nutrition
9.3. Tube Feeding
10. Enteral Nutrition Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Channel
10.4. Retail Pharmacies
11. Enteral Nutrition Market, by Age Group
11.1. Introduction
11.2. Adult
11.3. Pediatric
12. Enteral Nutrition Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Enteral Nutrition Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Enteral Nutrition Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. B. Braun Melsungen AG
16.3. Baxter International Inc.
16.4. Danone S.A.
16.5. DSM Nutritional Products AG
16.6. Fresenius Kabi AG
16.7. Global Health Products, Inc.
16.8. Hormel Foods Corporation
16.9. Kate Farms Inc.
16.10. Mead Johnson & Company, LLC
16.11. Medline Industries, Inc.
16.12. Medtrition Inc.
16.13. Meiji Holdings Co., Ltd.
16.14. Nestlé S.A.
16.15. Nutricia Advanced Medical Nutrition
16.16. Nutritional Medicinals, LLC
16.17. Otsuka Pharmaceutical Co., Ltd.
16.18. Perrigo Company plc
16.19. Primus Pharmaceuticals, Inc.
16.20. Real Food Blends LLC
16.21. Reckitt Benckiser Group PLC
16.22. Victus Inc.
List of Figures
FIGURE 1. GLOBAL ENTERAL NUTRITION MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ENTERAL NUTRITION MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ENTERAL NUTRITION MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ENTERAL NUTRITION MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ENTERAL NUTRITION MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY FORM, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ENTERAL NUTRITION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL ENTERAL NUTRITION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ENTERAL NUTRITION MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL BLENDERIZED DIET MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL BLENDERIZED DIET MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL BLENDERIZED DIET MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL SPECIALIZED FORMULAS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL SPECIALIZED FORMULAS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL SPECIALIZED FORMULAS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL DISEASE SPECIFIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL DISEASE SPECIFIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL DISEASE SPECIFIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL DIABETIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL DIABETIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL DIABETIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL HEPATIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL HEPATIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL HEPATIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL PULMONARY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL PULMONARY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL PULMONARY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL RENAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL RENAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL RENAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL FIBER ENRICHED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL FIBER ENRICHED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL FIBER ENRICHED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL IMMUNE MODULATING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL IMMUNE MODULATING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL IMMUNE MODULATING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL PROBIOTIC SUPPLEMENTED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL PROBIOTIC SUPPLEMENTED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL PROBIOTIC SUPPLEMENTED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL STANDARD FORMULAS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL STANDARD FORMULAS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL STANDARD FORMULAS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL MODULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL MODULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL MODULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL OLIGOMERIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL OLIGOMERIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL OLIGOMERIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL POLYMERIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL POLYMERIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL POLYMERIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL LIQUID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL LIQUID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL LIQUID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL POWDER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL POWDER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL POWDER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ORAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL ORAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL ORAL NUTRITION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL TUBE FEEDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL TUBE FEEDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL TUBE FEEDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ONLINE CHANNEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ONLINE CHANNEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ONLINE CHANNEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC ENTERAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 87. NORTH AMERICA ENTERAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. NORTH AMERICA ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 89. NORTH AMERICA ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 90. NORTH AMERICA ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 91. NORTH AMERICA ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 92. NORTH AMERICA ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 93. NORTH AMERICA ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 94. NORTH AMERICA ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 96. LATIN AMERICA ENTERAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. LATIN AMERICA ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 98. LATIN AMERICA ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 99. LATIN AMERICA ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 100. LATIN AMERICA ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 101. LATIN AMERICA ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 102. LATIN AMERICA ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 103. LATIN AMERICA ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 104. LATIN AMERICA ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 105. EUROPE ENTERAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. EUROPE ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 107. EUROPE ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 108. EUROPE ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 109. EUROPE ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 110. EUROPE ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 111. EUROPE ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 112. EUROPE ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 113. EUROPE ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 114. MIDDLE EAST ENTERAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. MIDDLE EAST ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 116. MIDDLE EAST ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 117. MIDDLE EAST ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 118. MIDDLE EAST ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 120. MIDDLE EAST ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 121. MIDDLE EAST ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 122. MIDDLE EAST ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 123. AFRICA ENTERAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. AFRICA ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 125. AFRICA ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 126. AFRICA ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 127. AFRICA ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 128. AFRICA ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 129. AFRICA ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 130. AFRICA ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 131. AFRICA ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. ASEAN ENTERAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. ASEAN ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 135. ASEAN ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 136. ASEAN ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 137. ASEAN ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 138. ASEAN ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 139. ASEAN ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 140. ASEAN ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 141. ASEAN ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 142. GCC ENTERAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. GCC ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 144. GCC ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 145. GCC ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 146. GCC ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 147. GCC ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 148. GCC ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 149. GCC ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 150. GCC ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION ENTERAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 160. BRICS ENTERAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 161. BRICS ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 162. BRICS ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 163. BRICS ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 164. BRICS ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 165. BRICS ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 166. BRICS ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 167. BRICS ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 168. BRICS ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 169. G7 ENTERAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 170. G7 ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 171. G7 ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 172. G7 ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 173. G7 ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 174. G7 ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 175. G7 ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 176. G7 ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 177. G7 ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 178. NATO ENTERAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 179. NATO ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 180. NATO ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 181. NATO ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 182. NATO ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 183. NATO ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 184. NATO ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 185. NATO ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 186. NATO ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 187. GLOBAL ENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 188. UNITED STATES ENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 189. UNITED STATES ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 190. UNITED STATES ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 191. UNITED STATES ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 192. UNITED STATES ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 193. UNITED STATES ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 194. UNITED STATES ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 195. UNITED STATES ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 196. UNITED STATES ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 197. CANADA ENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 198. CANADA ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 199. CANADA ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 200. CANADA ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 201. CANADA ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 202. CANADA ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 203. CANADA ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 204. CANADA ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 205. CANADA ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 206. MEXICO ENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 207. MEXICO ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 208. MEXICO ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 209. MEXICO ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 210. MEXICO ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 211. MEXICO ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 212. MEXICO ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 213. MEXICO ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 214. MEXICO ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 215. BRAZIL ENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 216. BRAZIL ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 217. BRAZIL ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 218. BRAZIL ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 219. BRAZIL ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 220. BRAZIL ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 221. BRAZIL ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 222. BRAZIL ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 223. BRAZIL ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 224. UNITED KINGDOM ENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 225. UNITED KINGDOM ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 226. UNITED KINGDOM ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 227. UNITED KINGDOM ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 228. UNITED KINGDOM ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 229. UNITED KINGDOM ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 230. UNITED KINGDOM ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 231. UNITED KINGDOM ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 232. UNITED KINGDOM ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 233. GERMANY ENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 234. GERMANY ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 235. GERMANY ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 236. GERMANY ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 237. GERMANY ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 238. GERMANY ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 239. GERMANY ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 240. GERMANY ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 241. GERMANY ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 242. FRANCE ENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 243. FRANCE ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 244. FRANCE ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 245. FRANCE ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 246. FRANCE ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 247. FRANCE ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 248. FRANCE ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 249. FRANCE ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 250. FRANCE ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 251. RUSSIA ENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 252. RUSSIA ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 253. RUSSIA ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 254. RUSSIA ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 255. RUSSIA ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 256. RUSSIA ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 257. RUSSIA ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 258. RUSSIA ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 259. RUSSIA ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 260. ITALY ENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 261. ITALY ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 262. ITALY ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 263. ITALY ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 264. ITALY ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 265. ITALY ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 266. ITALY ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 267. ITALY ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 268. ITALY ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 269. SPAIN ENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 270. SPAIN ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 271. SPAIN ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 272. SPAIN ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 273. SPAIN ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 274. SPAIN ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 275. SPAIN ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 276. SPAIN ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 277. SPAIN ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 278. CHINA ENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 279. CHINA ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 280. CHINA ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 281. CHINA ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 282. CHINA ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 283. CHINA ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 284. CHINA ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 285. CHINA ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 286. CHINA ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 287. INDIA ENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 288. INDIA ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 289. INDIA ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 290. INDIA ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 291. INDIA ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 292. INDIA ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 293. INDIA ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 294. INDIA ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 295. INDIA ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 296. JAPAN ENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 297. JAPAN ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 298. JAPAN ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 299. JAPAN ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 300. JAPAN ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 301. JAPAN ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 302. JAPAN ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 303. JAPAN ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 304. JAPAN ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 305. AUSTRALIA ENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 306. AUSTRALIA ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 307. AUSTRALIA ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 308. AUSTRALIA ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 309. AUSTRALIA ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 310. AUSTRALIA ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 311. AUSTRALIA ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 312. AUSTRALIA ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 313. AUSTRALIA ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 314. SOUTH KOREA ENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 315. SOUTH KOREA ENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 316. SOUTH KOREA ENTERAL NUTRITION MARKET SIZE, BY SPECIALIZED FORMULAS, 2017-2032 (USD MILLION)
TABLE 317. SOUTH KOREA ENTERAL NUTRITION MARKET SIZE, BY DISEASE SPECIFIC, 2017-2032 (USD MILLION)
TABLE 318. SOUTH KOREA ENTERAL NUTRITION MARKET SIZE, BY STANDARD FORMULAS, 2017-2032 (USD MILLION)
TABLE 319. SOUTH KOREA ENTERAL NUTRITION MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 320. SOUTH KOREA ENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 321. SOUTH KOREA ENTERAL NUTRITION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 322. SOUTH KOREA ENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 323. GLOBAL ENTERAL NUTRITION MARKET SHARE, BY KEY PLAYER, 2025
TABLE 324. GLOBAL ENTERAL NUTRITION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Danone S.A.
  • DSM Nutritional Products AG
  • Fresenius Kabi AG
  • Global Health Products, Inc.
  • Hormel Foods Corporation
  • Kate Farms Inc.
  • Mead Johnson & Company, LLC
  • Medline Industries, Inc.
  • Medtrition Inc.
  • Meiji Holdings Co., Ltd.
  • Nestlé S.A.
  • Nutricia Advanced Medical Nutrition
  • Nutritional Medicinals, LLC
  • Otsuka Pharmaceutical Co., Ltd.
  • Perrigo Company plc
  • Primus Pharmaceuticals, Inc.
  • Real Food Blends LLC
  • Reckitt Benckiser Group PLC
  • Victus Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.74 Billion
Forecasted Market Value ( USD ) by 2032 $ 13.99 Billion
Compound Annual Growth Rate10.1%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Home Enteral Nutrition Market - Global Forecast 2026-2032 - Product Image

Home Enteral Nutrition Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Enteral Nutrition Preparation Market - Global Forecast 2026-2032 - Product Image

Enteral Nutrition Preparation Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Enteral Nutrition - Global Strategic Business Report - Product Image

Enteral Nutrition - Global Strategic Business Report

  • Report
  • 379 Pages
  • Global
From
Enteral Nutrition Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Enteral Nutrition Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Enteral Nutrition Market Report 2026 - Product Image

Enteral Nutrition Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Enteral Nutrition Market

Enteral Nutrition is a form of nutrition therapy used to provide nutrition to patients who are unable to consume food orally. It is a form of pharmaceutical therapy that is used to provide essential nutrients to patients who are unable to consume food orally due to medical conditions such as dysphagia, gastrointestinal disorders, or other medical conditions. Enteral Nutrition is typically administered through a tube that is inserted into the stomach or small intestine. This form of nutrition therapy is used to provide essential nutrients such as proteins, carbohydrates, fats, vitamins, and minerals to patients who are unable to consume food orally. Enteral Nutrition is a growing market within the pharmaceutical industry. It is used to provide essential nutrients to patients who are unable to consume food orally due to medical conditions. This form of nutrition therapy is used to provide essential nutrients to patients who are unable to consume food orally due to medical conditions. Some companies in the Enteral Nutrition market include Nestle Health Science, Abbott Nutrition, B. Braun Melsungen AG, Fresenius Kabi, Danone Nutricia, and Mead Johnson Nutrition. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.